Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Chronic Hepatitis bTenofovir Alafenamide Fumarate

Interventions

DRUG

Tenofovir Alafenamide Tablets

Take 25mg TAF daily from week 28-32 of gestation until delivery

Trial Locations (1)

RECRUITING

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors

lead

First People's Hospital of Hangzhou

OTHER